Topical Collection "Feature Papers in Journal of Respiration"


Prof. Dr. Cesar A. Moran
E-Mail Website
Collection Editor
Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
Interests: thoracic pathology (lung, pleura, and mediastinum)
Special Issues, Collections and Topics in MDPI journals

Topical Collection Information

Dear Colleagues,

This topical collection for JoR has the goal to gather high-quality manuscripts in the form of review articles, original contributions, unusual case studies, and molecular or artificial intelligence analyses in the diverse areas that our journal covers: pulmonology, diagnostic imaging, pathology, surgery, oncology, and molecular analysis in either pediatric or adult populations. As you can see, the main goal of this topical collection is to illustrate the diversity and the wide spectrum of possibilities that our journal can offer.

Your being part of the Editorial Board of JoR plays an essential role in not only identifying possible guest editors to guide in the selections of topics for inclusion in JoR but also in taking the role of guest editor and contributing to the progress and advancement of the journal.  

Suggestions as Topical Collections include but are not limited to:

  • Diagnostic Imaging—the different techniques currently available for the diagnosis of the numerous conditions in the thorax;
  • Pulmonology—nontumoral conditions of the thorax: pleural and lung:
    • A topical collection of pleural diseases—diagnosis and treatment;
    • Topical collection of lung non-neoplastic conditions—diagnosis and treatment;
    • Lung neoplasia—diagnosis and treatment;
    • Pediatric pulmonary conditions;
    • Thoracic diseases—a focus on undeveloped countries: diagnostic and treatment options.
  • Surgery—A topical collection of the different approaches for the treatment of neoplastic conditions: thoracotomy, robotic procedures, other minimally invasive procedures.

If anyone of the Board Members would like to spearhead any of those suggestions or have a special recommendation for a guest editor for any of them, please get in touch. We will also welcome the opportunity to work with you if you prefer to develop your own Topical Collection.

Prof. Dr. Cesar A. Moran
Collection  Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Respiration is an international peer-reviewed open access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • respiratory system
  • pulmonology
  • pleural diseases
  • lung neoplasia
  • thoracic diseases
  • diagnostic imaging
  • diagnosis and treatment

Published Papers (1 paper)


Programmed Cell Death in SARS-CoV-2 Infection: A Short Review
J. Respir. 2021, 1(4), 223-228; - 24 Sep 2021
Viewed by 418
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the latest variant in the coronavirus family, causing COVID-19, has resulted in global pandemic since early 2020 leading to severe public health concern. So far, the pandemic has caused more than 200 million infections and 4 [...] Read more.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the latest variant in the coronavirus family, causing COVID-19, has resulted in global pandemic since early 2020 leading to severe public health concern. So far, the pandemic has caused more than 200 million infections and 4 million deaths worldwide. Most of the studies are focused on developing prevention, intervention, and therapeutic strategies. However, underlying pathophysiology of the disease is important as well, which needs further attention. Cell death is one of the major causative mechanisms that leads to severe inflammation, and it is also an a posteriori consequence of the hyperinflammatory storm that renders poor prognosis of the disease. Substantial cell death has been reported in biopsy samples from post mortem patients. Among the distinct cell death pathways, apoptosis, the regulated programmed cell death plays an important role in the pathogenesis of the disease. Understanding the role of SARS-CoV-2 infection in apoptosis is critical to linearize the pathogenesis of the virus as well as the resultant disease, that may uncover novel therapeutic targets in treatment of COVID-19 patients. Here, we review the current progress on the underlying molecular mechanism(s) of SARS-CoV-2-induced apoptosis, not only at the level of the virus but also at its individual proteins. Full article
Show Figures

Figure 1

Back to TopTop